血液透析患者心血管并发症的研究现状

被引:12
作者
邱强
陈香美
机构
[1] 解放军总医院肾内科
[2] 解放军肾病中心暨重点实验室
关键词
血液透析患者; 发病率; 死亡率; 心脏病; HD; 人口自然变动; 心脏疾病; 并发症; 并发病; 疾病; 心脏血管疾病; 心血管病; 透析病人;
D O I
暂无
中图分类号
R459.5 [透析疗法];
学科分类号
100215 ;
摘要
<正> 患有慢性肾功能衰竭的群体是心血管疾病(CVD)风险性增高的病人群体。许多病人在开始维持性透析治疗时已经存在有症状的心脏疾病。透析病人若合并心血管病,其年死亡率要比普通人群高得多。尽管慢性肾衰竭并发心血管病的发病率和死亡都很高,但是一直未引起人们足够的重视。直到近年,人们才开始重视慢性肾衰病人心血管病临床疾病的研究。
引用
收藏
页码:55 / 58
页数:4
相关论文
共 11 条
[1]  
Impact of hypertension on cardionmyopathy, morbidity and mortality in end stage renal disease. Robert N,Patick S,Partfrey,et al. Kidney International . 1996
[2]  
Port FK, Mauger EA.A comparison of cause of death between patients treate with hemodialysis and peritoneal dialysis. Bloembergen WE. Journal of the American Society of Nephrology . 1995
[3]  
The impact of anemia on cardiomyophy, morbidity and mortality in end stage renal disease. Rober N,Patick S. Parfrey,John,et al. American Journal of Kidney Diseases . 1996
[4]  
The clinical epidemiology of cardiac disease in chronic renal failure. Patrick S,Robert N. American Journal of Nephrology . 1999
[5]  
Sudden and cardiac death rates in hemodialysis patients. Anthony J Bleyer,Gregory B Russell,Scott G Satko. Kidney International . 1999
[6]  
Screening diabetic transplant candidates for coronary artery disease: Identification of a low-risk subgroup. Manske CL,Thomas W,wang Y,et al. Kidney International . 1993
[7]  
Mde of dialysis therapy and mortality in end stage renal disease. Foley RN,Parfrey PS,Harnett JD,et al. Journal of the American Society of Nephrology . 1998
[8]  
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epotin. Besarab A,Klion Bolton W,Browne JK,et al. The New England Journal of Medicine . 1998
[9]  
Outcome and risk facors of ischemic heart disease in chronic uremia. Parfrey PS,Foley RN,Harnett. Kidney International . 1996
[10]  
Long-team evolution of cardiomyopathy in dialysis patients. Foley RN,Parfrey PS,Kent GM,et al. Kidney International . 1998